首页> 外文会议>International Symposium on Medical and Pharmaceutical Biotechnology(医药生物技术国际研讨会) >Antigenic epitope analysis, expression and purification of truncated forms of herpes simplex virus type I glycoprotein D in eucaryotic expression system
【24h】

Antigenic epitope analysis, expression and purification of truncated forms of herpes simplex virus type I glycoprotein D in eucaryotic expression system

机译:真核表达系统中抗原性抗原表位的分析,截短形式的单纯疱疹病毒I型糖蛋白D的表达和纯化

获取原文
获取原文并翻译 | 示例

摘要

To identify the possihility that the truncated herpes simplex virus type I glycoprotein D (gD1) expressed in eukaryotic cells can be used as a subunit vaccine of herpes simplex virus. Firstly, antigenic epilopes of gD1 protein were screened by analyzing the amino acid sequences using Anthewin software. Then, the extracellular region fragment gene of gD1 with optimized signal peptide was synthesized chemically and cloned into eucaryotic expression vector pCEP4. After transfection of HEK 293 cells with the recombinant plasmid and selection with hygromycin B, finally, gD1 recombinant protein was expressed in culture medium and purified through Ni affinity chromatography. From the experiment, the recombinant plasmid pCEP4-gD1 harboring synthetic gene of gD1 epitope mass region was constructed successfully. The expressed protein was confirmed with SDS-PAGE and Western blot analysis. And one major protein band, with approximate molecular weights of 46 kDa corresponding to the truncated forms of gD1 protein, was observed. In addition, ELISA detection showed that expressed gD1 has good antigenicity. Based on the above result, the successfully cloning and expression of gD1 recombinant protein in eucaryotic expression cells provides a basis for developing HSV subunit vaccine.
机译:为了确定在真核细胞中表达的截短的I型单纯疱疹病毒糖蛋白D(gD1)可以用作单纯疱疹病毒的亚基疫苗的可能性。首先,使用Anthewin软件通过分析氨基酸序列筛选出gD1蛋白的抗原表位。然后,化学合成具有优化的信号肽的gD1的细胞外区域片段基因,并将其克隆到真核表达载体pCEP4中。用重组质粒转染HEK 293细胞并用潮霉素B筛选后,最终在培养基中表达gD1重组蛋白,并通过Ni亲和层析纯化。通过实验,成功构建了带有gD1表位质量区合成基因的重组质粒pCEP4-gD1。通过SDS-PAGE和蛋白质印迹分析确认表达的蛋白质。并观察到一条主要蛋白带,分子量约为46 kDa,对应于gD1蛋白的截短形式。另外,ELISA检测表明表达的gD1具有良好的抗原性。基于以上结果,gD1重组蛋白在真核表达细胞中的成功克隆和表达为开发HSV亚单位疫苗提供了基础。

著录项

  • 来源
  • 会议地点 Nanjing(CN)
  • 作者单位

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    The East-China Institute for Medical Biotechniques, Nanjing, 21002, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    The East-China Institute for Medical Biotechniques, Nanjing, 21002, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China The East-China Institute for Medical Biotechniques, Nanjing, 21002, China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    herpes simplex virus; gD1 protein; eucaryotic cell expression; antigenicity;

    机译:单纯疱疹病毒; gD1蛋白;真核细胞表达;抗原性;
  • 入库时间 2022-08-26 14:06:02

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号